• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    ZO® Skin Health Appoints Industry Veteran Justin Skala as CEO to Continue Strong Growth

    3/12/24 1:08:00 PM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary
    Get the next $CL alert in real time by email

    IRVINE, Calif., March 12, 2024 /PRNewswire/ -- ZO® Skin Health, a premium clinical dermatological skincare brand distributed globally through physicians and skincare professionals, today announced the appointment of Justin Skala as Chief Executive Officer. Mr. Skala brings more than 35 years of leadership experience growing high efficacy products through the professional channel, including driving the expansion of the personal care category over his tenure at Colgate-Palmolive, Inc. (NYSE:CL). He succeeds Mark Williams who will continue to serve the company on its Board of Directors.

    ZO Skin Health

    "Justin brings incredible experience fueling the growth of iconic personal care brands and successfully introducing innovative new products to market. His experience and commitment to serving patients with clinically efficacious regimens will be immensely valuable in driving continued growth at ZO® Skin Health," said Board Chair Todd Hirsch. "We are grateful to Mark for his many contributions to the company over the years and look forward to continue working together in his role as a member of the Board."

    Mr. Skala joins ZO® Skin Health from Standard Industries, a global leader in building solutions, solar technology and chemical products, where he served as Executive Chair of Standard Building Solutions and CEO of BMI Group. Previously, he served in various executive leadership roles at Colgate-Palmolive, Inc., where he led global strategy and growth for the company's vast portfolio of oral, personal, skin care, home care and pet nutrition products. Mr. Skala also sits on the board of Yum! Brands.

    "ZO® Skin Health is a pioneer in ensuring patients receive not only the most efficacious products, but also get maximal results from them by fostering the relationship between providers and their patients. I've long admired Dr. Obagi's vision for redefining the concept of skincare and could not be more excited to join this incredible team," said Mr. Skala. "I'm energized by the opportunity to continue expanding our product line and deepening our relationships with our network of physicians and their patients."

    "I am immensely proud of what we have built at ZO® Skin Health over the years and am grateful for such a wonderful partnership with our visionary founder Dr. Zein Obagi and the exceptional leadership team," said Mr. Williams.

    Founded in 2007 by world-renowned dermatologist Dr. Zein Obagi, the company continues to support its mission of providing healthy skin for all, regardless of age, ethnicity, unique skin condition or skin type, while utilizing the power of science to help pave the way for breakthroughs in skincare.

    "I have spent my entire life dedicated to helping patients have healthy skin through. Every year hundreds of thousands of patients benefit from our products and protocols – with their high-quality ingredients, tested formulas, exclusive medical protocols, and trusted recommendations," said Dr. Zein Obagi. "I look forward to working with Justin on the continued growth of ZO® Skin Health throughout the global medical community."

    About ZO® Skin Health

    ZO® Skin Health develops and delivers innovative skincare solutions that optimize skin health based on the latest advances in skin therapy technologies, unique delivery systems, bioengineered complexes and exclusive formulations. By providing comprehensive skincare programs for physicians and their patients, ZO® bridges the gap between therapeutic treatments and daily care, allowing patients to experience continuously healthy skin regardless of their age, ethnicity or unique skin condition. For more information, please visit www.zoskinhealth.com.

    Contact

    Jacqueline Porter

    [email protected]

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/zo-skin-health-appoints-industry-veteran-justin-skala-as-ceo-to-continue-strong-growth-302087042.html

    SOURCE ZO Skin Health

    Get the next $CL alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CL

    DatePrice TargetRatingAnalyst
    10/28/2024$105.00 → $101.00Buy → Hold
    Stifel
    9/24/2024$121.00Overweight
    Piper Sandler
    9/16/2024$100.00Equal Weight → Underweight
    Wells Fargo
    9/9/2024$107.00 → $109.00Buy → Hold
    Deutsche Bank
    7/26/2024Buy → Hold
    HSBC Securities
    7/24/2024$103.00 → $95.00Buy → Hold
    Jefferies
    7/23/2024$110.00Buy
    TD Cowen
    6/24/2024$109.00Outperform
    Exane BNP Paribas
    More analyst ratings

    $CL
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Colgate-Palmolive Webcasts Fireside Chat at the Goldman Sachs Global Staples Forum

      Colgate-Palmolive (NYSE:CL) President, Hill's Pet Nutrition, John Hazlin, and Chief Investor Relations Officer and EVP, M&A, John Faucher, will participate in a fireside chat at the Goldman Sachs Global Staples Forum on Tuesday, May 13, 2025 at 8:15 am ET. Investors may access a live webcast of this fireside chat on Colgate's website at www.colgatepalmolive.com. For those unable to participate during the live webcast, a recorded version of the webcast will be made available through the Investor Center page of Colgate's website. * * * Colgate-Palmolive Company is a caring, innovative growth company that is reimagining a healthier future for all people, their pets and our planet. Focused o

      4/29/25 10:15:00 AM ET
      $CL
      Package Goods/Cosmetics
      Consumer Discretionary
    • Colgate-Palmolive Webcasts 2025 Annual Meeting of Stockholders May 9, 2025 – 10:00 a.m. ET

      Colgate-Palmolive Company (NYSE:CL) will provide a live video webcast of its 2025 Annual Meeting of Stockholders on Friday, May 9, 2025 at 10:00 a.m. ET. Investors may access the live video webcast at www.virtualshareholdermeeting.com/CL2025. Access will be available beginning at 9:30 a.m. ET. For those unable to participate during the live webcast, a recorded version of the webcast will be made available on the Company's website approximately 24 hours after the meeting concludes. * * * Colgate-Palmolive Company is a caring, innovative growth company that is reimagining a healthier future for all people, their pets and our planet. Focused on Oral Care, Personal Care, Home Care and Pet Nu

      4/28/25 9:30:00 AM ET
      $CL
      Package Goods/Cosmetics
      Consumer Discretionary
    • Colgate Announces 1st Quarter 2025 Results

      Colgate-Palmolive Company (NYSE:CL): Net sales decreased 3.1%; Organic sales* increased 1.4%, including a 0.4% negative impact from lower private label pet volume; foreign exchange was a 4.4% headwind to net sales GAAP EPS increased 2% to $0.85; Base Business EPS* increased 6% to $0.91 GAAP Gross profit margin and Base Business Gross profit margin* increased 80 basis points to 60.8% Net cash provided by operations was $600 million for the first three months of 2025 Colgate's leadership in toothpaste continued with its global market share at 40.9% year to date Colgate's leadership in manual toothbrushes continued with its global market share at 31.9% year to date The Company up

      4/25/25 6:55:00 AM ET
      $CL
      Package Goods/Cosmetics
      Consumer Discretionary

    $CL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Norrington Lorrie M was granted 2,019 shares, increasing direct ownership by 6% to 38,079 units (SEC Form 4)

      4 - COLGATE PALMOLIVE CO (0000021665) (Issuer)

      5/14/25 4:21:59 PM ET
      $CL
      Package Goods/Cosmetics
      Consumer Discretionary
    • Director Nelson Kimberly A was granted 2,019 shares, increasing direct ownership by 28% to 9,360 units (SEC Form 4)

      4 - COLGATE PALMOLIVE CO (0000021665) (Issuer)

      5/14/25 4:22:02 PM ET
      $CL
      Package Goods/Cosmetics
      Consumer Discretionary
    • Director Newman Brian was granted 2,019 shares, increasing direct ownership by 78% to 4,621 units (SEC Form 4)

      4 - COLGATE PALMOLIVE CO (0000021665) (Issuer)

      5/14/25 4:21:55 PM ET
      $CL
      Package Goods/Cosmetics
      Consumer Discretionary

    $CL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Colgate-Palmolive downgraded by Stifel with a new price target

      Stifel downgraded Colgate-Palmolive from Buy to Hold and set a new price target of $101.00 from $105.00 previously

      10/28/24 7:38:39 AM ET
      $CL
      Package Goods/Cosmetics
      Consumer Discretionary
    • Piper Sandler initiated coverage on Colgate-Palmolive with a new price target

      Piper Sandler initiated coverage of Colgate-Palmolive with a rating of Overweight and set a new price target of $121.00

      9/24/24 7:35:59 AM ET
      $CL
      Package Goods/Cosmetics
      Consumer Discretionary
    • Colgate-Palmolive downgraded by Wells Fargo with a new price target

      Wells Fargo downgraded Colgate-Palmolive from Equal Weight to Underweight and set a new price target of $100.00

      9/16/24 7:25:35 AM ET
      $CL
      Package Goods/Cosmetics
      Consumer Discretionary

    $CL
    Leadership Updates

    Live Leadership Updates

    See more
    • Give Kids A Smile Program Celebrates 23rd Year of Providing Free Oral Health Care Services to Underserved Children

      The American Dental Association Foundation's Initiative, with Exclusive National Sponsors Henry Schein and Colgate-Palmolive, Continues to Expand Its Reach, With Nearly 325,500 Children Expected to Receive Care Throughout 2025 The American Dental Association Foundation (ADA Foundation) is celebrating the 23rd year of its Give Kids A Smile® (GKAS) program, which officially launched on Friday, February 7, at the 2025 national kick-off event at Meharry Medical College School of Dentistry. Since its national launch in 2003, GKAS volunteers have provided free oral health education and services to more than 9.5 million underserved children in the U.S. This press release features multimedia. Vi

      2/10/25 6:30:00 AM ET
      $CL
      $HSIC
      Package Goods/Cosmetics
      Consumer Discretionary
      Medical Specialities
      Health Care
    • ZO® Skin Health Appoints Industry Veteran Justin Skala as CEO to Continue Strong Growth

      IRVINE, Calif., March 12, 2024 /PRNewswire/ -- ZO® Skin Health, a premium clinical dermatological skincare brand distributed globally through physicians and skincare professionals, today announced the appointment of Justin Skala as Chief Executive Officer. Mr. Skala brings more than 35 years of leadership experience growing high efficacy products through the professional channel, including driving the expansion of the personal care category over his tenure at Colgate-Palmolive, Inc. (NYSE:CL). He succeeds Mark Williams who will continue to serve the company on its Board of Directors.

      3/12/24 1:08:00 PM ET
      $CL
      Package Goods/Cosmetics
      Consumer Discretionary
    • Colgate-Palmolive Company Appoints Lorrie Norrington as Lead Independent Director of the Board

      Colgate-Palmolive Company (NYSE:CL) today announced that its Board of Directors has appointed Lorrie Norrington as Lead Independent Director, effective March 1, 2023. Ms. Norrington will succeed Stephen I. Sadove, the Company's current Lead Independent Director. Mr. Sadove will remain on the Audit and Personnel and Organization Committees of the Colgate Board of Directors. Ms. Norrington joined the Company's Board in September 2015 and currently serves as Chair of the Nominating, Governance and Corporate Responsibility Committee. She brings extensive global corporate leadership, digital, e-commerce and ESG experience to this role, including her experience in several senior management roles

      1/3/23 4:30:00 PM ET
      $CL
      Package Goods/Cosmetics
      Consumer Discretionary

    $CL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Colgate-Palmolive Company (Amendment)

      SC 13G/A - COLGATE PALMOLIVE CO (0000021665) (Subject)

      2/13/24 5:02:36 PM ET
      $CL
      Package Goods/Cosmetics
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Colgate-Palmolive Company (Amendment)

      SC 13G/A - COLGATE PALMOLIVE CO (0000021665) (Subject)

      2/9/23 11:15:26 AM ET
      $CL
      Package Goods/Cosmetics
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Colgate-Palmolive Company (Amendment)

      SC 13G/A - COLGATE PALMOLIVE CO (0000021665) (Subject)

      2/9/22 3:43:30 PM ET
      $CL
      Package Goods/Cosmetics
      Consumer Discretionary

    $CL
    Financials

    Live finance-specific insights

    See more
    • Colgate Announces 1st Quarter 2025 Results

      Colgate-Palmolive Company (NYSE:CL): Net sales decreased 3.1%; Organic sales* increased 1.4%, including a 0.4% negative impact from lower private label pet volume; foreign exchange was a 4.4% headwind to net sales GAAP EPS increased 2% to $0.85; Base Business EPS* increased 6% to $0.91 GAAP Gross profit margin and Base Business Gross profit margin* increased 80 basis points to 60.8% Net cash provided by operations was $600 million for the first three months of 2025 Colgate's leadership in toothpaste continued with its global market share at 40.9% year to date Colgate's leadership in manual toothbrushes continued with its global market share at 31.9% year to date The Company up

      4/25/25 6:55:00 AM ET
      $CL
      Package Goods/Cosmetics
      Consumer Discretionary
    • Colgate-Palmolive Webcasts 2025 First Quarter Earnings Conference Call April 25, 2025 – 8:30 a.m. ET

      Colgate-Palmolive Company (NYSE:CL) will provide a live webcast of its 2025 first quarter earnings conference call on Friday, April 25, 2025, at 8:30 a.m. ET. The call will be hosted by Chairman, President and CEO, Noel Wallace, Chief Financial Officer, Stan Sutula, and Chief Investor Relations Officer and EVP, M&A, John Faucher. Investors may access the earnings press release, prepared materials and the live audio webcast on Colgate's website at https://investor.colgatepalmolive.com/events-and-presentations. For those unable to participate during the live webcast, a recorded version of the webcast will be made available through the Investor Center section of Colgate's website. * * * Colg

      4/11/25 9:30:00 AM ET
      $CL
      Package Goods/Cosmetics
      Consumer Discretionary
    • Colgate Announces Dividend Increase and New $5 Billion Share Repurchase Program

      The Board of Directors of Colgate-Palmolive Company (NYSE:CL) today increased the quarterly common stock cash dividend to $.52 up from $.50 per share. The increase will be effective in the second quarter, 2025. The Board declared that the second quarter dividend is to be paid on May 15, 2025 to shareholders of record as of April 17, 2025. On an annual basis, the new dividend rate is $2.08 vs. $2.00 per share previously. The Company has paid uninterrupted dividends on its common stock since 1895. Share Repurchase Program The Board of Directors today also authorized the repurchase of shares of the Company's common stock having an aggregate purchase price of up to $5 billion under a new shar

      3/20/25 4:35:00 PM ET
      $CL
      Package Goods/Cosmetics
      Consumer Discretionary

    $CL
    SEC Filings

    See more
    • Colgate-Palmolive Company filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - COLGATE PALMOLIVE CO (0000021665) (Filer)

      5/14/25 4:41:05 PM ET
      $CL
      Package Goods/Cosmetics
      Consumer Discretionary
    • Colgate-Palmolive Company filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - COLGATE PALMOLIVE CO (0000021665) (Filer)

      5/2/25 4:05:29 PM ET
      $CL
      Package Goods/Cosmetics
      Consumer Discretionary
    • SEC Form FWP filed by Colgate-Palmolive Company

      FWP - COLGATE PALMOLIVE CO (0000021665) (Subject)

      4/28/25 5:23:30 PM ET
      $CL
      Package Goods/Cosmetics
      Consumer Discretionary